Red Abbey Venture Partners

Red Abbey Venture Partners is a venture capital firm specializing in early-stage investments in the life sciences sector. The firm focuses on companies developing novel therapeutics and other products based on distinctive technologies. Their investment strategy capitalizes on advances in molecular biology, drug discovery, and medical treatment to address unmet medical needs.

The firm has invested in 15 privately held and 9 publicly traded life sciences companies. Their portfolio includes companies such as Advanced Biohealing, Alba Therapeutics, Anacor Pharmaceuticals, CoGenesys, Corridor Pharmaceuticals, Kemia, Kmia, MacroGenics, Nereus Pharmaceuticals, Novelion Therapeutics, Oxagen Limited, StroMedix, and Veran Medical Technologies.

Red Abbey Venture Partners is led by founding members Frank A. Bonsal, Jr. and Philip Goelet, PhD. The firm's investment committee also includes Matt Zuga and Mark Adler, MD. The firm is based in Lutherville Timonium, Maryland, and can be contacted at (410) 494-4230 or via email through their website.